Cargando…
Genomic testing for rare disease diagnosis—where are we now, and where should we be heading? The reflections of a behavioural scientist
Autor principal: | Lewis, Celine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620131/ https://www.ncbi.nlm.nih.gov/pubmed/37528189 http://dx.doi.org/10.1038/s41431-023-01439-0 |
Ejemplares similares
-
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
The impact of ICCPR's Global Audit of Cardiac Rehabilitation: where are we now and where do we need to go?
por: Turk-Adawi, Karam, et al.
Publicado: (2023) -
COVID-19 and liver disease: where are we now?
por: Russo, Francesco Paolo, et al.
Publicado: (2022) -
Vitamin D for COVID-19: where are we now?
por: Martineau, Adrian R., et al.
Publicado: (2022) -
Pulse Crop Genetics for a Sustainable Future: Where We Are Now and Where We Should Be Heading
por: Sahruzaini, Nurul Amylia, et al.
Publicado: (2020)